(VIANEWS) – Shares of Tilray (NASDAQ: TLRY) jumped by a staggering 10.71% to $2.79 at 14:39 EST on Friday, after two consecutive sessions in a row of gains. NASDAQ is jumping 2.16% to $12,225.17, after four consecutive sessions in a row of losses. This seems, as yet, an all-around positive trend trading session today.
Tilray’s last close was $2.52, 58.21% below its 52-week high of $6.03.
About Tilray
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Earnings Per Share
As for profitability, Tilray has a trailing twelve months EPS of $-3.25.
Volume
Today’s last reported volume for Tilray is 13928634 which is 21.01% above its average volume of 11509700.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Tilray’s stock is considered to be oversold (<=20).
More news about Tilray (TLRY).
